TCEAL2 antibody
Principal name
TCEAL2 antibody
Alternative names for TCEAL2 antibody
TCEA-like protein 2, My048, MY0876G0, Transcription elongation factor A protein-like 2, Transcription elongation factor S-II protein-like 2
SwissProt ID
Q9H3H9 (Human)
Gene ID
140597 (TCEAL2)
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of TCEAL2 antibody
TCEAL2 is a member of the transcription elongation factor A (SII)-like (TCEAL) gene family. Members of this family contain TFA domains and may function as nuclear phosphoproteins that modulate transcription in a promoter context-dependent manner.This gene encodes a member of the transcription elongation factor A (SII)-like (TCEAL) gene family. Members of this family contain TFA domains and may function as nuclear phosphoproteins that modulate transcription in a promoter context-dependent manner. Multiple family members are located on the X chromosome.
General readings
Ross,M.T., (2005) Nature 434 (7031), 325-337
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP311139 | TCEAL2 |
||||
| Recombinant protein of human transcription elongation factor A (SII)-like 2 (TCEAL2) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP710155 | TCEAL2 (full length, C-term DDK tag) |
||||
| Recombinant protein of human transcription elongation factor A (SII)-like 2 (TCEAL2), full length, with C-terminal DDK tag, expressed in sf9, 20ug | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
SF9 cells |
20 µg /
€411.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY409183 | TCEAL2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |